Phase II Clinical Trial Suggests Treatment Pre-Surgery Safe and Effective Option for Localized Non-Small Cell Lung Cancer

Newswise — COLUMBUS, Ohio – New study data shows that the immuno-oncology drug, atezolizumab (pronounced  a”…

December 2023 Options Now Available For Surgery Partners (SGRY)

Investors in Surgery Partners Inc (Symbol: SGRY) saw new options begin trading today, for the December…